Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | -0.2 | -0.3 | 0.1 | 0.5 | 1,467.5 | 1,988.2 |
Revenue growth | -43.6% | -376.4% | -75.8% | -100.0% | -26.2% | |
Cost of goods sold | -0.2 | -0.2 | 0.4 | 1.0 | 1,697.2 | 1,882.6 |
Gross profit | 0.0 | -0.1 | -0.3 | -0.6 | -229.7 | 105.6 |
Gross margin | -4.4% | 38.0% | -262.4% | -120.4% | -15.7% | 5.3% |
Sales and marketing | 1.7 | 0.7 | 0.3 | 0.1 | 209.9 | 451.0 |
Research and development | 0.7 | 0.4 | 0.1 | 0.3 | 295.5 | 348.7 |
General and administrative | 3.2 | 4.1 | 1.3 | 2.8 | 1,567.7 | 942.8 |
EBIT | -6.7 | -5.6 | -2.4 | -3.8 | -2,302.8 | -1,636.9 |
EBIT margin | 3886.3% | 1816.8% | -2148.2% | -828.7% | -156.9% | -82.3% |
Pre-tax income | -6.9 | -13.5 | -4.1 | -5.2 | -3,510.0 | -2,717.7 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -6.9 | -13.5 | -4.1 | -5.2 | -3,510.0 | -2,717.7 |
Net margin | 3986.3% | 4396.6% | -3652.2% | -1139.9% | -239.2% | -136.7% |
|
Diluted EPS | ($0.55) | ($1.30) | ($8.35) | ($11.78) | $6,750,021.15 | |
Shares outstanding (diluted) | 12.5 | 10.4 | 0.5 | 0.4 | 0.0 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|